Nephroprotective role of nanoencapsulated Tinospora cordifolia (Willd.) using polylactic acid nanoparticles in streptozotocin‐induced diabetic nephropathy rats

Currently, the field of nanomedicine, which uses active compounds from medicinal plants, has emerged as a therapy for diabetic nephropathy. From this study, the renoprotective effect of TC‐loaded PLA Nanoparticles (TC‐PLA NPs) on streptozotocin (STZ)‐induced diabetic nephropathy rats was investigated. The results showed that the nephroprotective effect of TC‐PLA NPs reduces the blood glucose level, regulates the renal parameters, decreases the cytokine levels and reduces the mRNA expressions level of different genes related to diabetic nephropathy.     

Zinc oxide nanoparticles augment CD4, CD8, and GLUT‐4 expression and restrict inflammation response in streptozotocin‐induced diabetic rats

This study evaluated the biochemical, molecular, and histopathological mechanisms involved in the hypoglycaemic effect of zinc oxide nanoparticles (ZnONPs) in experimental diabetic rats. ZnONPs were prepared by the sol–gel method and characterised by scanning and transmission electron microscopy (SEM and TEM). To explore the possible hypoglycaemic and antioxidant effect of ZnONPs, rats were grouped as follows: control group, ZnONPs treated group, diabetic group, and diabetic + ZnONPs group. Upon treatment with ZnONPs, a significant alteration in the activities of superoxide dismutase, glutathione peroxidase, and the levels of insulin, haemoglobin A1c, and the expression of cluster of differentiation 4+ (CD4+), CD8+ T cells, glucose transporter type‐4 (GLUT‐4), tumour necrosis factor, and interleukin‐6 when compared to diabetic and their control rats. ZnONPs administration to the diabetic group showed eminent blood glucose control and restoration of the biochemical profile. This raises their active role in controlling pancreas functions to improve glycaemic status as well as the inflammatory responses. Histopathological investigations showed the non‐toxic and therapeutic effect of ZnONPs on the pancreas. TEM of pancreatic tissues displayed restoration of islets of Langerhans and increased insulin‐secreting granules. This shows the therapeutic application of ZnONPs as a safe anti‐diabetic agent and to have a potential for the control of diabetes.Inspec keywords: nanoparticles, transmission electron microscopy, cellular biophysics, sugar, nanomedicine, nanofabrication, zinc compounds, molecular biophysics, biochemistry, tumours, enzymes, biomedical materials, biological organs, blood, diseases, patient treatment, II‐VI semiconductors, wide band gap semiconductors, scanning electron microscopy, sol‐gel processing, semiconductor growthOther keywords: molecular mechanisms, histopathological mechanisms, zinc oxide nanoparticles, experimental diabetic rats, hypoglycaemic effect, antioxidant effect, control group, diabetic group, CD4+, CD8+ T cells, glucose transporter type‐4, control rats, GLUT‐4 expression, streptozotocin‐induced diabetic rats, biochemical mechanisms, safe antidiabetic agent, inflammation response, sol‐gel method, transmission electron microscopy, scanning electron microscopy, SEM, TEM, superoxide dismutase, glutathione peroxidase, insulin levels, haemoglobin A1c, differentiation 4+ T cells, tumour necrosis factor, interleukin‐6, blood glucose control, pancreas functions, glycaemic status, therapeutic effect, pancreatic tissues, Langerhans islets, insulin‐secreting granules, ZnO     

Nano‐encapsulated Tinospora cordifolia (Willd.) using poly (D,L‐lactide) nanoparticles educe effective control in streptozotocin‐induced type 2 diabetic rats

The therapeutics for type 2 diabetes mellitus has emerged in the current century towards nanomedicine incorporated with plant active compounds. In this study, Tinospora cordifolia loaded poly (D, L‐lactide) (PLA) nanoparticles (NPs) were evaluated in vivo for their anti‐hyperglycemic potency towards streptozotocin‐induced type 2 diabetic rats. T. cordifolia loaded PLA NPs were synthesised by the double solvent evaporation method using PLA polymer. The NPs were then characterised and administrated orally for 28 successive days to streptozotocin‐induced diabetic rats. The PLA NPs had significant anti‐diabetic effects which were equal to the existing anti‐diabetic drug glibenclamide. The antidiabetic activity is due to the synergism of compounds present in stem extract of the plant which reduced the side effects and anti‐diabetic.Inspec keywords: blood, nanofabrication, drug delivery systems, biochemistry, evaporation, nanoparticles, nanomedicine, drugs, diseases, polymers, biomedical materialsOther keywords: PLA nanoparticles, antidiabetic effects, nanoencapsulated Tinospora cordifolia, streptozotocin‐induced type 2 diabetic rats, type 2 diabetes mellitus, poly(d, l‐lactide) nanoparticles, diabetic drug glibenclamide, nanomedicine, antihyperglycemic potency, double‐solvent evaporation     

Photo‐induced Leishmania DNA degradation by silver‐doped zinc oxide nanoparticle: an in‐vitro approach

Recently, the authors reported newly synthesised polyethylene glycol (PEG)ylated silver (9%)‐doped zinc oxide nanoparticle (doped semiconductor nanoparticle (DSN)) which has high potency for killing Leishmania tropica by producing reactive oxygen species on exposure to sunlight. The current report is focused on Leishmania DNA interaction and damage caused by the DSN. Here, we showed that the damage to Leishmania DNA was indirect, as the DSN was unable to interact with the DNA in intact Leishmania cell, indicating the incapability of PEGylated DSN to cross the nucleus barrier. The DNA damage was the result of high production of singlet oxygen on exposure to sunlight. The DNA damage was successfully prevented by singlet oxygen scavenger (sodium azide) confirming involvement of the highly energetic singlet oxygen in the DNA degradation process.Inspec keywords: silver, zinc compounds, nanoparticles, nanomedicine, DNA, microorganisms, cellular biophysics, biomedical engineeringOther keywords: photo‐induced Leishmania DNA degradation, PEGylated silver‐doped zinc oxide nanoparticle, Leishmania tropica, reactive oxygen species, sunlight, Leishmania DNA interaction, Leishmania cell, DNA damage, singlet oxygen scavenger, sodium azide, DNA degradation process, ZnO:Ag     

Acute toxicity of ferric oxide and zinc oxide nanoparticles in rats

We investigated the toxic effects of inhalation exposure to ferric oxide (Fe2O3) and zinc oxide (ZnO) nanoparticles in rats. Male Wistar rats were consecutively treated with Fe22O3 at 8.5 mg/kg body weight and ZnO nanoparticles at 2.5 mg/kg body weight, twice daily for 3 days. Content of Fe2O3 and ZnO in tissues, biochemical parameters in serum, and hispathological examinations were analyzed at 12 h and 36 h after the 3 day treatment. In the Fe2O3-treated group, iron (Fe) content in liver and lung tissues was significantly increased at 36 h. In the ZnO-treated group, zinc (Zn) content in liver tissues was significantly increased at 12 h and further increased at 36 h. The levels of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), total protein (TP), creatine kinase (CK), and lactate dehydrogenase (LDH) in both nanoparticle-exposed groups were significantly decreased compared to the unexposed controls. Histopathological examination showed that both types of nanoparticles caused severe damage in liver and lung tissues. Although this damage progressed in both liver and lung throughout the postexposure period, no significant elevation of serum enzyme activities was observed in response to either nanoparticle type.     

Microwave‐mediated synthesis of zinc oxide nanoparticles: a therapeutic approach against Malassezia species

A successful protocol was developed to aid in the reduction in dandruff‐causing fungi, namely Malassezia globasa and Malassezia furfur. Both the species were isolated from volunteers aged between 20 and 22 suffering from dandruff, cultured ex vivo, and tested against the presence of synthesised zinc oxide nanoparticles (ZnNP). Direct microscopy, scanning electron microscopy (SEM), and biochemical assays specific to Malassezia species were conducted to identify dandruff‐causing fungal species. Microwave‐mediated synthesis of ZnNP was performed and characterised by UV–vis, X‐ray diffraction, and SEM. The nanoparticles were tested against both Malassezia species and proved highly effective in inhibiting these fungi, although M. furfur was more susceptible than M. globosa. An optimum amount of 100 ppm was found to be sufficient to work as an antifungal agent. Synergistic effects of ZnNP with commercial shampoos were tested, and the result showed enhanced antifungal effects. To mimic the natural biofilm formed by these species on human skin, the formation of fungal biofilm was allowed on polystyrene coverslips. ZnNP was effective in eradication biofilm. Since zinc is an essential mineral for all living organism and is considered as biocompatible, the synthesised nanomaterials can be used in the formulation of antidandruff shampoos.Inspec keywords: skin, X‐ray diffraction, antibacterial activity, scanning electron microscopy, biochemistry, biomedical materials, nanoparticles, nanofabrication, visible spectra, zinc compounds, microorganisms, ultraviolet spectra, nanomedicineOther keywords: Malassezia furfur, Malassezia species, fungal species, microwave‐mediated synthesis, Malassezia globasa, zinc oxide nanoparticles, dandruff‐causing fungi, scanning electron microscopy, direct microscopy, biochemical assays, UV–visible spectroscopy, X‐ray diffraction, antifungal agent, natural biofilm, eradication biofilm, antidandruff shampoos, human skin, ZnO     

Nephron ultrastructural alterations induced by zinc oxide nanoparticles: an electron microscopic study

Due to their unique properties, zinc oxide nanoparticles (ZnO NPs) are invested in many industries, commercial products, and nanomedicine with potential risk for human health and the environment. The present study aims to focus on alterations that might be induced by ZnO NPs in the nephron ultrastructure. Male Wister Albino rats were subjected to ZnO NPs at a daily dose of 2 mg/kg for 21 days. Kidney biopsies were processed to transmission electron microscopy (TEM) and ultrastructural pathology examinations. Exposure to ZnO NPs‐induced ultrastructural alterations in the proximal convoluted tubules (PCTs) and to lesser extent in the distal ones (DCTs), while the loops of Henle were almost not affected. The glomeruli demonstrated dilatation, partial mesangial cells loss, matrix ballooning, slits filtration widening, and basement membrane thickening. Moreover, PCT revealed cytoplasmic necrosis, vacuolation, erosion, and disorganisation of the apical microvilli together with mitochondrial swelling and cristae destruction. The nuclei of the renal cells exhibited nuclear deformity, heterochromatin accumulation, and apoptotic activities. The findings indicate that ZnO nanomaterial have the potential to affect the nephron ultrastructure suggesting alteration in the kidney functions. More work is needed for better understanding the toxicity and pathogenesis of ZnO oxide nanomaterial.Inspec keywords: electron microscopy, zinc compounds, transmission electron microscopy, nanomedicine, biochemistry, diseases, cellular biophysics, biomembranes, kidney, nanofabrication, molecular biophysics, nanoparticles, II‐VI semiconductors, biomedical optical imagingOther keywords: electron microscopic study, unique properties, zinc oxide nanoparticles, ZnO NPs, nephron ultrastructure, Male Wister Albino rats, ultrastructural pathology examinations, NPs‐induced ultrastructural alterations, partial mesangial cells loss, ZnO nonmaterial, ZnO oxide nonmaterial, nephron ultrastructural alterations, kidney biopsies, time 21.0 d, ZnO     

Sliding‐mode‐based controllers for automation of blood glucose concentration for type 1 diabetes

Destruction of β‐cells in pancreas causes deficiency in insulin production that leads to diabetes in the human body. To cope with this problem, insulin is either taken orally during the day or injected into the patient''s body using artificial pancreas (AP) during sleeping hours. Some mathematical models indicate that AP uses control algorithms to regulate blood glucose concentration (BGC). The extended Bergman minimal model (EBMM) incorporates, as a state variable, the disturbance in insulin level during medication due to either meal intake or burning sugar by engaging in physical exercise. In this research work, EBMM and proposed finite time robust controllers are used, including the sliding mode controller (SMC), backstepping SMC (BSMC) and supertwisting SMC (second‐order SMC or SOSMC) for automatic stabilisation of BGC in type 1 diabetic patients. The proposed SOSMC diminishes the chattering phenomenon which appears in the conventional SMC. The proposed BSMC is a recursive technique which becomes robust by the addition of the SMC. Lyapunov theory has been used to prove the asymptotic stability of the proposed controllers. Simulations have been carried out in MATLAB/Simulink for the comparative study of the proposed controllers under varying data of six different type 1 diabetic patients available in the literature.     

Design of 3‐aminophenol‐grafted polymer‐modified zinc sulphide nanoparticles as drug delivery system

Zinc sulphide (ZnS) nanoparticles were synthesized by the coprecipitation method. The ZnS nanoparticle surface was polymerized with allyl glycidyl ether (AGE), and 3‐aminophenol was then deposited as a ligand on nanosorbent. The modified nanosorbent was investigated with Fourier transform infrared spectroscopy and thermogravimetric analysis. The particle size of the modified nanosorbent was studied with scanning electron microscopy. Some characteristic factors of the adsorption process such as pH and time were investigated for famotidine using the modified nanosorbent. The equilibrium adsorption study of famotidine by 3‐aminophenol‐grafted AGE/ZnS was analysed by adsorption isotherms of the Langmuir, Freundlich, and Temkin models. The famotidine‐releasing process was investigated in simulated biological fluids (intestinal fluid at pH of 7.4 and gastric fluid at pH of 1.2) and demonstrated 65% and 73% famotidine release during periods of 30 h (pH = 7.4) and 60 min (pH = 1.2), respectively. These results reveal the optimal performance of 3‐aminophenol‐grafted AGE/ZnS for sustained drug delivery.     

Formation of zinc oxide nanoparticles by mechanochemical reaction

Abstract

The synthesis of zinc oxide (ZnO) nanocrystallites by mechanochemical reaction of ZnCl₂ and Na₂CO₃ with NaCl as diluent and following thermal treatment was investigated using X-ray diffraction (XRD) and transmission electron microscopy (TEM). Calcination of the as milled powder at 600°C in air and removal of NaCl through washing formed ZnO nanocrystallites with an average crystal size of ~ 21 nm, which increased with increasing thermal treatment temperature. Milling time and NaCl/ZnCl₂ molar ratio exerted prominent effects on the crystal size of the ZnO nanoparticles. The mechanism of nanocrystallite growth is discussed.     

Nephroprotective effect of Bryophyllum pinnatum‐mediated silver nanoparticles in ethylene glycol‐induced urolithiasis in rat

A large population is suffering from multifactorial urolithiasis worldwide with a reoccurrence rate of almost 70%–80% in males and 47%–60% in females. In the present study, the nephroprotective effect of silver nanoparticles (AgNPs) synthesised by Bryophyllum pinnatum was evaluated in ethylene glycol‐induced urolithiasis in rat. B. pinnatum‐mediated AgNPs which were found to be spherical and polydispersed particles with an average size of 32.65 nm determined by transmission electron microscopy analysis, and showing an absorption peak at 432 nm by the UV‐Vis spectrophotometric analysis, revealing the role of hydroxyl group in the synthesis by Fourier Transformed Infrared Spectroscopy analysis, with a zeta potential value of −15.7 mV. The crystalline nature and fcc structure was demonstrated based on X‐ray diffraction analysis. Animal study was performed on 36 male Wistar rats divided into six equal groups, which demonstrated significant increase in serum total protein, albumin and globulin and significant decrease in AST, ALT, creatinine, BUN, calcium and phosphorus in group V and VI when compared with group II and IV. No crystalluria was observed in rats given B. pinnatum AgNPs. Histopathological observations in group V and VI showed mild degenerative changes and restoration or maintenance of kidney parenchyma when compared with group II and IV rats. Thus, the authors conclude with the beneficial preventive and therapeutic nephroprotective effect of B. pinnatum‐mediated AgNPs against ethylene glycol‐induced urolithiasis in rats.     

Cu‐induced assembly of methanobactin‐modified gold nanoparticles and its peroxidase mimic activity

Methanobactin (Mb) is a small copper‐chelating molecule that functions as an agent for copper acquisition, uptake and copper‐containing methane monooxygenase catalysis in methane‐oxidising bacteria. The UV–visible spectral and fluorescence spectral suggested that Mb/Cu coordination complex as a monomer (Mb‐Cu), dimmer (Mb₂ ‐Cu) and tetramer (Mb₄ ‐Cu) could be obtained at different ratios of Mb to Cu (II). The kinetics of the oxidation of hydroquinone with hydrogen peroxide catalysed by the different Mb/Cu coordination complex were investigated. The results suggested that Mb₂ ‐Cu coordination form has highest catalytic capacity. Further, Mb‐modified gold nanoparticles (AuNPs) were obtained by ligand exchange and assembled into two‐ and three‐D nanocluster structure by metal‐organic coordination as driving force. It has been found that AuNPs increased the catalytic activity of Mb₂ ‐Cu on AuNPs. The more significant catalytic activity was exhibited by the nanocluster assembly with multi‐catalytic centres. This may be attributed to the multivalent collaborative characteristics of the catalytic active centres in the nanocluster network assembly. The assembly of Mb‐modified AuNPs can act as excellent nanoenzyme models for imitating peroxidase.Inspec keywords: nanoparticles, catalysis, oxidation, enzymes, microorganisms, nanobiotechnology, gold, organic compounds, reduction (chemical), visible spectra, molecular biophysics, ultraviolet spectra, biochemistry, copper, nanofabrication, fluorescenceOther keywords: Mb‐modified gold nanoparticles, catalytic active centres, Mb‐modified AuNPs, Cu‐induced assembly, methanobactin‐modified gold nanoparticles, peroxidase mimic activity, copper‐chelating molecule, copper‐containing methane monooxygenase catalysis, methane‐oxidising bacteria, fluorescence, Mb/Cu coordination complex, catalytic activity, UV–visible spectra, nanocluster assembly, Cu, Au     

Robust multi‐objective blood glucose control in Type‐1 diabetic patient

In this study, an automatic robust multi‐objective controller has been proposed for blood glucose (BG) regulation in Type‐1 Diabetic Mellitus (T1DM) patient through subcutaneous route. The main objective of this work is to control the BG level in T1DM patient in the presence of unannounced meal disturbances and other external noises with a minimum amount of insulin infusion rate. The multi‐objective output‐feedback controller with H_∞, H₂ and pole‐placement constraints has been designed using linear matrix inequality technique. The designed controller for subcutaneous insulin delivery was tested on in silico adult and adolescent subjects of UVa/Padova T1DM metabolic simulator. The experimental results show that the closed‐loop system tracks the reference BG level very well and does not show any hypoglycaemia effect even during the long gap of a meal at night both for in silico adults and adolescent. In the presence of 50 gm meal disturbance, average adult experience normoglycaemia 92% of the total simulation time and hypoglycaemia 0% of total simulation time. The robustness of the controller has been tested in the presence of irregular meals and insulin pump noise and error. The controller yielded robust performance with a lesser amount of insulin infusion rate than the other designed controllers reported earlier.Inspec keywords: robust control, patient treatment, diseases, closed loop systems, patient monitoring, biochemistry, medical control systems, blood, organic compoundsOther keywords: robust multiobjective blood glucose control, automatic robust multiobjective controller, blood glucose regulation, Type‐1 Diabetic Mellitus patient, BG level, T1DM patient, insulin infusion rate, multiobjective output‐feedback controller, pole‐placement constraints, linear matrix inequality technique, subcutaneous insulin delivery, total simulation time, insulin pump noise, adolescent subjects, meal disturbance, normoglycaemia 92, in silico adults, UVa‐Padova T1DM metabolic simulator, closed‐loop system, hypoglycaemia effect     

Postprandial anti‐hyperglycemic activity of marine Streptomyces coelicoflavus SRBVIT13 mediated gold nanoparticles in streptozotocin induced diabetic male albino Wister rats

The present study focuses on the biosynthesis of gold nanoparticles (AuNPs) using Streptomyces coelicoflavus (S. coelicoflavus) SRBVIT13 isolated from marine salt pan soils collected from Ongole, Andhra Pradesh, India. The biosynthesised AuNPs are characterised by UV–visible spectroscopy, X‐ray diffraction, Fourier transform infrared spectroscopy, high‐resolution transmission electron microscopy and energy‐dispersive X‐ray analysis. Transmission electron microscopy study suggests that the biosynthesised AuNPs are spherical in shape within a size range of 12–20 nm (mean diameter as 14 nm). The anti‐type II diabetes activity of AuNPs is carried out by testing it in vitro α ‐glucosidase and α ‐amylase enzyme inhibition activity and in vivo postprandial anti‐hyperglycemic activity in sucrose and glucose‐loaded streptozotocin induced diabetic albino Wister rats. AuNPs has shown a significant inhibitory activity of 84.70 and 87.82% with IC₅₀ values of 67.65 and 65.59 μg/mL to α ‐glucosidase and α ‐amylase enzymes, while the diabetic rats have shown significant reduction in the post postprandial blood glucose level by 57.80 and 88.09%, respectively compared with control group after AuNPs treatment at the concentration of 300 and 600 mg/kg body weight. Hence, this biosynthesised AuNPs might be useful in combating type II diabetes mellitus for the betterment of human life.Inspec keywords: gold, nanoparticles, ultraviolet spectra, visible spectra, X‐ray diffraction, Fourier transform infrared spectra, transmission electron microscopy, X‐ray chemical analysis, diseases, enzymes, nanomedicine, biochemistry, spectrochemical analysisOther keywords: gold nanoparticles, Streptomyces coelicoflavus SRBVIT13, biosynthesis, UV–visible spectroscopy, X‐ray diffraction, Fourier transform infrared spectroscopy, high‐resolution transmission electron microscopy, energy‐dispersive X‐ray analysis, antitype II diabetes activity, in vitro enzyme inhibition activity, in vivo postprandial antihyperglycemic activity, streptozotocin induced diabetic albino Wister rats, type II diabetes mellitus, Au     

Synthesis of zinc and zinc oxide nanoparticles from zinc electrode using plasma in liquid

Nanoparticles are synthesized efficiently from zinc electrode by microwave plasma in liquid. The nanoparticles synthesized from alcohol resulted in pure zinc particles in the shape of spheres or hexagonal cylinders with a production rate of 3.3 g/h, and energy consumption of 267 J/mg for 1 mg. Whereas the nanoparticles synthesized in pure water are composed of Zn and ZnO. The Zn reacts with water through heat or the passage of time to become ZnO, releasing hydrogen gas. An upper disk placed 1 mm away from the electrode along with the bubbles generated simultaneously with the plasma ignition plays a key role in the synthesis of nanoparticles.     

Blood glucose concentration control for type 1 diabetic patients: a multiple‐model strategy

In this study, a multiple‐model strategy is evaluated as an alternative closed‐loop method for subcutaneous insulin delivery in type 1 diabetes. Non‐linearities of the glucose–insulin regulatory system are considered by modelling the system around five different operating points. After conducting some identification experiments in the UVA/Padova metabolic simulator (accepted simulator by the US Food and Drug Administration (FDA)), five transfer functions are obtained for these operating points. Paying attention to some physiological facts, the control objectives such as the required settling time and permissible bounds of overshoots and undershoots are determined for any transfer functions. Then, five PID controllers are tuned to achieve these objectives and a bank of controllers is constructed. To cope with difficulties of the presence of delays in subcutaneous blood glucose (BG) measuring and in administration of insulin, a glucose‐dependent setpoint is considered as the desired trajectory for the BG concentration. The performance of the obtained closed‐loop glucose–insulin regulatory system is investigated on the in silico adult cohort of the UVA/Padova metabolic simulator. The obtained results show that the proposed multiple‐model strategy leads to a closed‐loop mechanism with limited hyperglycemia and no severe hypoglycemia.Inspec keywords: blood, patient diagnosis, medical control systems, biochemistry, three‐term control, closed loop systems, diseases, patient treatment, drugs, sugarOther keywords: blood glucose concentration control, type 1 diabetic patients, multiple‐model strategy, alternative closed‐loop method, subcutaneous insulin delivery, type 1 diabetes, transfer functions, control objectives, PID controllers, subcutaneous blood glucose measuring, glucose‐dependent setpoint, closed‐loop glucose–insulin regulatory system, closed‐loop mechanism     

Sialic acid‐conjugated PLGA nanoparticles enhance the protective effect of lycopene in chemotherapeutic drug‐induced kidney injury

Lycopene (LYC) is known to protect cells from oxidative damage caused by free radicals in human tissues. In the present study, the authors designed a LYC‐loaded sialic acid (SA)‐conjugated poly(D,L‐lactide‐co‐glycolide) (PLGA) nanoparticle (LYC‐NP) to enhance the therapeutic efficacy of LYC in acute kidney injury. The characteristics of the LYC‐NPs were defined according to particle size, morphology, and in vitro drug release. The LYC‐NPs exhibited a controlled release of LYC over 48 h. Confocal laser scanning microscopy clearly highlighted the targeting potential of SA. Enhanced green fluorescence was observed for the LYC‐NPs in H₂ O₂ ‐treated human umbilical vein endothelial cells, indicating enhanced internalisation of NPs. The LYC‐NPs showed significantly greater cell viability than H₂ O₂ ‐treated cells. In addition, the LYC‐NPs remarkably reduced proinflammatory cytokine levels, attributable mainly to the increased cellular internalisation of the SA‐based carrier delivery system. Furthermore, protein levels of caspase‐3 and ‐9 were significantly down‐regulated after treatment with the LYC‐NPs. Overall, they have demonstrated that SA‐conjugated PLGA‐NPs containing LYC could be used to treat kidney injury.Inspec keywords: fluorescence, biomedical materials, biological tissues, cellular biophysics, drugs, proteins, molecular biophysics, injuries, drug delivery systems, kidney, nanomedicine, biochemistry, optical microscopy, nanoparticles, nanofabrication, cancer, toxicology, blood vessels, particle sizeOther keywords: sialic acid‐conjugated PLGA nanoparticles, chemotherapeutic drug‐induced kidney injury, LYC‐NP, LYC‐loaded sialic acid‐conjugated poly(D,L‐lactide‐co‐glycolide) nanoparticle, SA‐conjugated PLGA‐NP, protective effect, lycopene, human tissues, particle size, in vitro drug release, confocal laser scanning microscopy, green fluorescence, human umbilical vein endothelial cells, cell viability, proinflammatory cytokine levels, cellular internalisation, SA‐based carrier delivery system, time 48.0 hour     

Evaluation of antifungal effect of iron‐oxide nanoparticles against different Candida species

Iron‐oxide nanoparticles (IONPs) have been widely favoured due to their biodegradable, low cytotoxic effects and having reactive surface which can be altered with biocompatible coatings. Considering various medical applications of IONPs, the authors were encouraged to study whether IONPs could be effective against fungal infections caused by Candida species. In this study, IONPs were characterised by scanning electron microscopy, X‐ray diffraction, Fourier transform infrared spectroscopy and vibrating sample magnetometer. The goal of this study was to evaluate the antifungal activity of IONPs against different Candida spp. compared with fluconazole (FLC). IONPs were spherical with the size of 30–40 nm. The minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) values of IONPs ranged from 62.5 to 500 µg/ml and 500 to 1000 μg/ml, respectively. The MIC and MFC of FLC were in range of 16–128 μg/ml and 64–512 μg/ml, respectively. The growth inhibition value indicated that Candida tropicalis, Candida albicans and Candida glabrata spp. were most susceptible to IONPs. The finding showed that the IONPs possessed antifungal potential against pathogenic Candida spp. and could inhibit the growth of all the tested Candida spp. Further studies, both in vitro and in vivo (including susceptibility, toxicity, Probability of kill (PK) and efficacy studies) are needed to determine whether IONPs are suitable for medicinal purposes.Inspec keywords: iron compounds, nanoparticles, nanomedicine, biomedical materials, microorganisms, cellular biophysics, toxicology, drugs, scanning electron microscopy, X‐ray diffraction, Fourier transform infrared spectraOther keywords: antifungal effect, iron‐oxide nanoparticles, Candida species, biodegradable effects, cytotoxic effects, reactive surface, biocompatible coatings, medical applications, IONP, fungal infections, Candidiasis, immunocompromised hosts, antifungal drugs, resistant organisms, antifungal properties, side effects, chemical drugs, scanning electron microscopy, X‐ray diffraction, Fourier transform infrared spectroscopy, vibrating sample magnetometer, antifungal activity, disc diffusion, broth microdilution, minimal inhibitory concentration, minimum fungicidal concentration, Candida tropicalis, Candida Albicans, Candida glabrata, antifungal potential, Fe₃ O₄      

Blood glucose regulation in type 1 diabetic patients: an adaptive parametric compensation control‐based approach

Here, a direct adaptive control strategy with parametric compensation is adopted for an uncertain non‐linear model representing blood glucose regulation in type 1 diabetes mellitus patients. The uncertain parameters of the model are updated by appropriate design of adaptation laws using the Lyapunov method. The closed‐loop response of the plasma glucose concentration as well as external insulin infusion rate is analysed for a wide range of variation of the model parameters through extensive simulation studies. The result indicates that the proposed adaptive control scheme avoids severe hypoglycaemia and gives satisfactory performance under parametric uncertainty highlighting its ability to address the issue of inter‐patient variability.Inspec keywords: patient monitoring, adaptive control, diseases, Lyapunov methods, closed loop systems, medical control systems, patient treatment, medical computing, sugar, uncertain systems, blood, nonlinear control systems, physiological modelsOther keywords: blood glucose regulation, type 1 diabetic patients, adaptive parametric compensation control‐based approach, direct adaptive control strategy, nonlinear model, type 1 diabetes mellitus patients, uncertain parameters, appropriate design, adaptation laws, closed‐loop response, plasma glucose concentration, external insulin infusion rate, model parameters, adaptive control scheme, parametric uncertainty, inter‐patient variability     

Blood glucose concentration control for type 1 diabetic patients: a non‐linear suboptimal approach

In this study, a closed‐loop treatment strategy is proposed for the control of blood glucose levels in type 1 diabetic patients. Toward this end, a non‐linear technique for designing suboptimal tracking controllers, called the state‐dependent Riccati equation tracker, is used based on a mathematical model of the glucose–insulin regulatory system. Since two state variables of the utilised model are not available to the controller, a non‐linear filter is also designed to estimate these variables using the measured blood glucose concentration. Effects of unannounced meals and regular exercise are investigated for a nominal patient and nine diabetic patients with unknown parameters. Numerical simulations are given to show the effectiveness of the proposed treatment strategy even in the presence of parametric uncertainties and the observation noise.Inspec keywords: blood, biochemistry, diseases, patient treatment, Riccati equations, nonlinear filters, medical signal processingOther keywords: blood glucose concentration control, type 1 diabetic patients, nonlinear suboptimal approach, closed‐loop treatment strategy, suboptimal tracking controllers, state‐dependent Riccati equation tracker, glucose‐insulin regulatory system, nonlinear filter, unannounced meals, regular exercise, treatment strategy, parametric uncertainties, observation noise